BUFFALO, N.Y., Nov. 29, 2011 /PRNewswire/ -- Buffalo Heart Group, LLP, 2011: Today Dr. ZakiMasud, Kaleida Health, Buffalo, NY announced its first implant of the AngelMed Guardian cardiac monitor and alert system. The system is designed to reduce the time it takes patients to get to the emergency room during an impending heart attack. Dr. Hashmat Ashraf, performed the first implant in the state of New York, and is among the very first physicians across the United States to implant the experimental device.
(Photo: http://photos.prnewswire.com/prnh/20111129/NY13888  )
The AngelMed Guardian system is designed to track significant changes in the heart's electrical signal and then alert patients to seek medical attention. The objective of the ALERTS Pivotal Study is to provide an assessment of the safety and effectiveness of the AngelMed Guardian System.
David Garland, a 7th grade teacher at JFK in Buffalo, NY is the first patient in New York enrolled in the ALERTS study to receive the AngelMed Guardian System. David had a heart attack in July and underwent stent placement. He has a strong family history of heart disease; his symptoms included fatigue and "indigestion like" pain and had symptoms for weeks before his heart attack.
David Garland was successfully implanted with the device by Dr. Ashraf of Kaleida Health Millard Fillmore Gates Hospital.
Quote from Principal Investigator: "This study provides an excellent opportunity for some of our patients who are at high-risk of having another heart attack. The device is designed to measure changes in the electrical signal of the heart and alert the patient at the earliest onset of a heart attack so that they can get treatment as soon as possible."
According to the American Heart Association, one of every five deaths in the US is attri